Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisa...

Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 14, Status: Authorised       geestelijk verzorger van GGZ NHN Jantien de Vries gaat voor in digi-viering over het rechte pad       Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised Human medicines European public assessment report (EPAR): Vaniqa, eflornithine, Hirsutism, Date of authorisation: 19/03/2001, Revision: 23, Status: Authorised

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.